Unknown OBSERVATIONAL NCT05647941

Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1

Non-invasive Response Assessment of Neo-adjuvant Chemotherapy in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1

Sponsor: Chinese PLA General Hospital

Conditions Chemotherapy Effect Gastric Cancer

Interventions Detection of levels of circulating EV-derived lncRNA-GC1

Updated 4 times since 2023 Last updated: Dec 12, 2022 Started: Jan 1, 2018 Primary completion: Dec 30, 2022 Completion: Dec 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chemotherapy Effect and Gastric Cancer and is currently ongoing. Chinese PLA General Hospital leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Jan 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Jan 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese PLA General Hospital

Data source: Chinese PLA General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China